Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.33 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PTAFR | P25105 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18776731 | 0.89 | ALDH1A1 (0.36) | CRHR1ENPP3ENPP1ALDH1A1CYP3A4 | |
| SCHEMBL18777173 | 0.89 | ALDH1A1 (0.36) | CRHR1ENPP3ENPP1ALDH1A1CYP3A4 | |
| SCHEMBL18776740 | 0.88 | ALDH1A1 (0.33) | CRHR1ALDH1A1CYP3A4HPGDTSHR | |
| SCHEMBL19770448 | 0.88 | ALDH1A1 (0.37) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL18776741 | 0.88 | ALDH1A1 (0.30) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL15461362 | 0.85 | KDM4E (0.30) | ALDH1A1HPGD | |
| SCHEMBL18776706 | 0.85 | CRHR1 (0.33) | CRHR1 | |
| SCHEMBL18776722 | 0.84 | ALDH1A1 (0.38) | CRHR1ENPP3ENPP1ALDH1A1CYP3A4 | |
| SCHEMBL18777040 | 0.84 | CRHR1 (0.31) | CRHR1 | |
| SCHEMBL18777213 | 0.83 | CRHR1 (0.34) | CRHR1ENPP3ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200091435-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-03-19 | — | — | US | disclosed |
| EP-3605635-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-10435350-B2 | Organic electroluminecence device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-10-08 | — | — | US | disclosed |
| US-20190023648-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-01-24 | — | — | US | disclosed |
| US-9902687-B2 | Compound | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-27 | — | — | US | disclosed |
| US-9902687-B2 | Compound | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-27 | — | — | US | disclosed |
| US-20170183291-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170183291-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170117469-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
| US-20170117469-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183291-A1 | NOVEL COMPOUND | RB1, RNF10, RBBP5 | CRHR1 278/4885ENPP3 4599/4885ENPP1 4159/4885 |
| US-20170117469-A1 | NOVEL COMPOUND | RB1, RNF10, RBBP5 | CRHR1 278/4885ENPP3 4599/4885ENPP1 4159/4885 |
| US-20190023648-A1 | NOVEL COMPOUND | RB1, RNF10, RBBP5 | CRHR1 278/4885ENPP3 4599/4885ENPP1 4159/4885 |
| US-10435350-B2 | Organic electroluminecence device | RB1, RCOR1, RBBP4 | CRHR1 307/4885ENPP3 3601/4885ENPP1 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.